WhatsApp
Urinary Bladder

Bladder Cancer - Profile

Pelvic & Uro-Oncosurgeon | Robotic Uro-Oncologic Surgeon | Bladder Cancer Surgeon

Ahmedabad, Gujarat, India

Dr. Swati H. Shah is a Pelvic and Uro-Oncosurgeon with 18+ years of experience in cancer surgery and 13+ years of experience in robotic surgery, with a focused practice in urological and pelvic cancers.

She specialises in the surgical management of urinary bladder, prostate, kidney, testicular, penile and complex pelvic cancers, using open, laparoscopic and robotic approaches according to the cancer stage, anatomy, previous treatment and patient’s overall condition.

Her practice combines uro-oncology, robotic surgery and complex pelvic oncology, with particular expertise in technically demanding cancer operations where the urinary tract, pelvic organs, lymph nodes and surrounding structures may be involved.

She practices at Apollo Hospital International, Ahmedabad, and at Shah’s Cancer & Robotic Surgery Centre, Gota, Ahmedabad.

Education & Surgical Training

Dr. Swati Shah completed her:

  • MBBS from Maulana Azad Medical College, New Delhi
  • MS in General Surgery from Maulana Azad Medical College, New Delhi
  • DrNB in Surgical Oncology from Rajiv Gandhi Cancer Institute, New Delhi
  • Dedicated training and experience in Uro-Oncology and pelvic cancer surgery
  • Advanced training in robotic cancer surgery
  • Robotic surgery certification through Intuitive Surgical

Her surgical training included extensive exposure to urological cancers, pelvic malignancies and complex cancer surgery.

During her specialist surgical oncology training, she developed focused experience in the management of prostate, kidney, bladder and other uro-oncological cancers.

She was also part of a high-volume robotic oncology environment in Delhi and gained early experience with robotic uro-oncological surgery before robotic cancer surgery became established in Gujarat.

Bladder Cancer Experience

Dr. Swati Shah has been involved in the surgical treatment of urinary bladder cancer since 2008.

She has been performing:

  • TURBT since 2008
  • Radical cystectomy since 2008
  • Robotic radical cystectomy since 2013
  • Robotic neobladder reconstruction since 2013

She has performed approximately 150 bladder cancer surgical procedures, including endoscopic, laparoscopic, open and robotic procedures.

Her bladder cancer practice includes both the removal of the cancer and, when the bladder needs to be removed, planning and performing appropriate urinary reconstruction.

Bladder Cancer Surgical Expertise

Dr. Shah performs and has experience with:

Endoscopic surgery

  • TURBT
  • Repeat TURBT
  • Endoscopic management and assessment of bladder tumours

Bladder cancer resection

  • Radical cystectomy
  • Robotic radical cystectomy
  • Open radical cystectomy
  • Laparoscopic radical cystectomy
  • Partial cystectomy in selected cases

Male bladder cancer surgery

  • Radical cystoprostatectomy
  • Pelvic lymph-node dissection
  • Complex bladder cancer surgery

Female bladder cancer surgery

  • Radical cystectomy with hysterectomy where indicated
  • Pelvic lymph-node dissection
  • Selected organ-preserving approaches
  • Complex pelvic cancer surgery involving the urinary bladder

Urinary reconstruction

  • Ileal conduit
  • Orthotopic neobladder
  • Robotic intracorporeal neobladder reconstruction
  • Ureteric reconstruction
  • Ureteric reimplantation
  • Ureterectomy
  • Distal ureterectomy with bladder cuff

Complex pelvic cancer surgery

  • Bladder cancer with adjacent-organ involvement
  • Recurrent pelvic malignancy involving the bladder
  • Post-treatment pelvic cancer
  • Post-radiation pelvic surgery
  • Pelvic exenteration involving cystectomy
  • Anterior exenteration
  • Complex uro-gynaecologic pelvic surgery

Robotic Radical Cystectomy & Neobladder

A major area of Dr. Shah’s expertise is robotic radical cystectomy with urinary reconstruction.

She has been performing robotic radical cystectomy since 2013, with experience in robotic cystoprostatectomy, pelvic lymph-node dissection and urinary diversion.

Her surgical experience includes neobladder reconstruction, including completely robotic approaches in selected patients.

Her approach is not limited to removal of the urinary bladder. Treatment planning also considers what happens after cystectomy:

Cancer removal → lymph-node dissection → urinary diversion/reconstruction → functional recovery

Depending on the patient’s cancer, anatomy, age, general health, renal function, urethral suitability and other factors, urinary reconstruction may include an ileal conduit or an orthotopic neobladder.

Complex Pelvic Oncology

Dr. Shah’s combined background in uro-oncology and gynecologic/pelvic oncology provides experience in cancers involving multiple pelvic organs.

She manages selected complex pelvic cancers involving:

  • Urinary bladder
  • Ureters
  • Prostate
  • Cervix
  • Uterus
  • Vagina
  • Rectum
  • Pelvic lymph nodes
  • Other pelvic structures

This experience is particularly relevant when cancer surgery requires detailed understanding of the relationships between the urinary, reproductive and gastrointestinal organs.

Her practice includes selected pelvic exenteration and anterior exenteration procedures, where radical cystectomy forms part of a larger cancer operation.

Experience in Recurrent and Previously Treated Pelvic Cancer

Dr. Shah also performs selected complex pelvic cancer operations in patients who have previously undergone treatment such as:

  • Chemotherapy
  • Radiation therapy
  • Previous pelvic surgery
  • Previous cancer surgery

Such cases require detailed review of imaging, previous treatment, tumour location and the possibility of achieving complete cancer removal.

Her published work on pelvic exenteration for recurrent or persistent cervical cancer evaluated 25 patients who underwent preoperative PET-CT and pelvic MRI for assessment of pelvic disease and surgical resectability.

The study reported R0 resection in all 25 patients, robotic surgery in selected patients, major complications in 8%, and no perioperative mortality.

The publication supports the concept that, in carefully selected patients with recurrent or persistent cervical cancer confined to the pelvis, radical pelvic surgery can offer a meaningful possibility of long-term disease control and cure.

This work is relevant to her broader expertise in complex pelvic cancer surgery involving radical cystectomy and urinary diversion, rather than being represented as a bladder-cancer-specific publication.

Multidisciplinary Bladder Cancer Care

Bladder cancer treatment is not always a single-operation decision.

Treatment may involve:

  • Uro-oncology
  • Surgical oncology
  • Medical oncology
  • Radiation oncology
  • Radiology
  • Pathology
  • Anaesthesia
  • Specialist nursing and postoperative rehabilitation

Dr. Shah follows a multidisciplinary approach in which the treatment plan is based on the patient’s tumour stage, histopathology, imaging, previous treatment, fitness and overall goals.

For appropriate patients, the pathway may involve:

Haematuria / bladder lesion → cystoscopy → TURBT → histopathology → staging → multidisciplinary treatment planning → systemic therapy and/or surgery → urinary reconstruction → follow-up

The exact sequence is individualised according to the type and stage of bladder cancer.

Robotic Uro-Oncology Experience

Dr. Shah has been performing robotic cancer surgery since 2013.

Her robotic uro-oncology experience includes:

  • Robotic radical prostatectomy
  • Robotic partial nephrectomy
  • Robotic radical nephrectomy
  • Robotic radical cystectomy
  • Robotic radical cystoprostatectomy
  • Robotic neobladder reconstruction
  • Robotic lymph-node dissection
  • Robotic retroperitoneal lymph-node dissection
  • Robotic pelvic cancer surgery
  • Robotic surgery for selected complex pelvic malignancies

She has performed approximately 650 robotic uro-gynaecologic cancer surgeries as part of her broader robotic oncology experience.

Academic & Teaching Experience

Dr. Shah is actively involved in academic uro-oncology, robotic surgery education and surgical teaching.

Her academic work includes:

  • National and international journal publications
  • Scientific paper presentations
  • Surgical video presentations
  • Robotic surgery master video sessions
  • Invited lectures
  • Faculty roles at national and international conferences
  • Panel discussions
  • Multidisciplinary academic meetings
  • Webinars
  • Surgical teaching sessions
  • Training of surgeons and urologists in robotic cancer surgery

Her academic presentations have included uro-oncological and robotic procedures involving kidney and bladder cancer, as well as prostate, testicular and complex pelvic cancers.

Robotic Cystectomy & Neobladder Teaching

Dr. Shah has presented robotic cystectomy, cystoprostatectomy and neobladder surgery through surgical videos, academic meetings, webinars and teaching sessions.

Her robotic uro-oncology surgical work has been presented to professional audiences in different cities across India and through online academic platforms.

These presentations focus on:

  • Surgical planning
  • Pelvic anatomy
  • Cancer-safe dissection
  • Pelvic lymph-node dissection
  • Robotic cystectomy
  • Cystoprostatectomy
  • Urinary reconstruction
  • Neobladder formation
  • Intracorporeal reconstruction
  • Management of complex pelvic anatomy

Her surgical videos provide professional audiences with case-based demonstrations of advanced robotic uro-oncological techniques.

Conference & Faculty Contributions

Dr. Shah has participated as a faculty member, speaker, moderator or presenter at professional surgical and oncology meetings.

Her academic involvement includes conferences and forums associated with:

  • Association of Surgeons of India (ASI / ASICON)
  • Indian Association of Surgical Oncology (IASO / IASOCON)
  • Robotic Urology Forum (RUFCON)
  • Association of Gynecologic Oncologists of India (AGOI / AGOICON)
  • Society of Endoscopic and Laparoscopic Surgeons of India (SELSI / SELSICON)
  • Indian Medical Association (IMA)
  • European Association of Urology (EAU)
  • European Society of Gynaecological Oncology (ESGO)
  • Other national and international surgical and oncology academic forums

Documented academic activities include robotic uro-oncology master video sessions at ASICON, RUFCON and IASOCON, a best video presentation at NATCON 2021, and invited faculty participation at meetings including ENDO LAP MAMC and the West Zone Urology Society of India.

She has also participated in national multidisciplinary oncology panel discussions and robotic surgery workshops.

Robotic Surgery Teaching

Dr. Shah has contributed to surgical education by teaching urologists and surgeons from across India about robotic uro-oncology.

Her teaching includes:

  • Robotic surgical techniques
  • Robotic pelvic cancer surgery
  • Robotic uro-oncology
  • Lymph-node dissection
  • Complex pelvic anatomy
  • Cancer-safe robotic dissection
  • Minimally invasive oncological surgery
  • Case-based surgical decision-making

She has conducted and participated in robotic surgery workshops, surgical video sessions, webinars and academic teaching programmes.

Her teaching philosophy emphasises that robotic surgery is a tool used by the surgeon, and that good robotic cancer surgery depends on oncological principles, anatomical understanding, appropriate patient selection and meticulous surgical technique.

PROM & POINT — Multidisciplinary Pelvic Oncology Education

Dr. Shah has also developed multidisciplinary academic platforms bringing different cancer specialists together for focused discussion of pelvic malignancies.

PROM — Pelvic Radiology & Oncology Meeting

PROM brings together specialists such as radiologists and oncologists to discuss pelvic cancer imaging, diagnosis, staging, treatment planning and complex cases.

The programme includes discussion of urological and pelvic cancers, including renal and bladder tumours.

POINT — Pathology, Oncology, Immunology & Novel Therapeutics

POINT is a multidisciplinary academic platform bringing together pathology and oncology perspectives for discussion of tumour biology, pathology, treatment decisions, immunology and newer systemic therapies.

The programme has included discussions relevant to uro-oncology and pelvic cancers, including kidney and bladder malignancies.

These initiatives reflect Dr. Shah’s interest not only in performing surgery, but also in improving multidisciplinary cancer decision-making and cross-specialty education.

Academic Recognition

Dr. Shah has received recognition for scientific paper presentations at professional meetings including:

  • SELSICON
  • RGCON
  • IASG
  • IMSCON
  • NATCON

She has also received recognition for surgical video presentations, including the Best Video Presentation on Robotic Retroperitoneal Lymph Node Dissection at NATCON 2021, New Delhi.

She is the author/co-author of multiple publications in national and international journals related to:

  • Cancer surgery
  • Robotic surgery
  • Pelvic oncology
  • Minimally invasive surgical oncology
  • Complex cancer surgery

She has also served in academic/reviewer roles for oncology journals.

Professional Memberships

Dr. Shah is associated with professional organisations including:

  • Association of Surgeons of India (ASI)
  • Indian Association of Surgical Oncology (IASO)
  • Association of Gynecologic Oncologists of India (AGOI)
  • European Society of Gynaecological Oncology (ESGO)
  • Society of Endoscopic and Laparoscopic Surgeons of India (SELSI)
  • Indian Medical Association (IMA)
  • European Association of Urology (EAU)

Surgical Philosophy

Dr. Shah’s approach to cancer surgery is based on four principles:

1. Cancer-safe surgery

The primary objective is appropriate oncological clearance based on the cancer type and stage.

2. Individualised treatment

Not every bladder cancer requires the same operation. Treatment is planned according to pathology, stage, imaging, previous treatment, anatomy and patient fitness.

3. Organ and function preservation where appropriate

When oncologically safe, preservation of healthy organs and important functions is considered.

4. Reconstruction and quality of life

For patients requiring bladder removal, treatment planning extends beyond cancer removal to urinary reconstruction and postoperative quality of life.

Patient-Centred Bladder Cancer Care

Patients seeking bladder cancer treatment may need answers to several different questions:

  • Do I need another TURBT?
  • Is my bladder cancer muscle-invasive?
  • Do I need bladder removal?
  • Can radical cystectomy be performed robotically?
  • What happens after bladder removal?
  • Will I need an external urine bag?
  • Can I have a neobladder?
  • Is an ileal conduit or neobladder more appropriate for me?
  • What happens after cystectomy?
  • Can complex or recurrent bladder cancer still be operated on?
  • What happens if the cancer involves nearby pelvic organs?
  • Should chemotherapy be given before surgery?
  • Where should I seek a second opinion?

Dr. Shah’s bladder cancer practice is designed to address these decisions through stage-based treatment planning, cancer-focused surgery, urinary reconstruction and multidisciplinary care.

Real-World Clinical Evidence

Dr. Shah’s bladder cancer website includes a growing clinical library consisting of:

  • Bladder cancer case summaries
  • Robotic cystectomy cases
  • Radical cystoprostatectomy cases
  • Neobladder cases
  • Ileal conduit cases
  • TURBT cases
  • Complex and recurrent bladder cancer cases
  • Video testimonials
  • Patient reviews
  • Short educational videos
  • Surgical videos

These cases demonstrate the range of bladder cancer presentations and surgical approaches rather than presenting robotic surgery as a one-size-fits-all treatment.

Current Practice

Dr. Swati H. Shah
Pelvic & Uro-Oncosurgeon | Robotic Uro-Oncologic Surgeon

Primary areas of bladder cancer expertise:

TURBT | Radical Cystectomy | Robotic Radical Cystectomy | Radical Cystoprostatectomy | Pelvic Lymph-Node Dissection | Ileal Conduit | Neobladder | Robotic Intracorporeal Reconstruction | Complex Pelvic Cancer Surgery | Recurrent Pelvic Cancer Surgery

Practice locations:

Shah’s Cancer & Robotic Surgery Centre, Gota, Ahmedabad

Apollo Hospital International, Ahmedabad/Gandhinagar

Education Videos

Short videos

In this case, laparoscopic surgery was performed for bladder cancer, with careful dissection and safe removal of the tumour specimen. Minimally invasive techniques may offer advantages such as smaller incisions, less postoperative pain, reduced blood loss and earlier mobilization, although the benefits and suitability depend on the type, stage and location of the cancer and the patient’s overall condition.

The tumour specimen was removed safely, and the patient had a smooth postoperative recovery and was discharged on the fifth day.

The smaller scars are one visible benefit of minimally invasive surgery, but the primary goal remains complete and safe cancer treatment. The choice between laparoscopic, robotic, open or other approaches should always be individualized based on the cancer and the patient.

The goal of radical cystectomy is to achieve complete removal of the cancer with adequate surgical margins while addressing possible spread to regional lymph nodes. Careful dissection and attention to anatomical planes are essential to ensure a thorough and safe oncological procedure.

Robotic surgery can provide a magnified 3D view, precise instrument control and enhanced dexterity, which can be particularly useful during complex pelvic cancer surgery. However, the choice of surgical approach depends on the cancer stage, anatomy, patient’s overall condition and the expertise of the surgical team.

The surgical specimen is carefully examined by the pathology team to assess the tumour, lymph nodes and surgical margins. Clear margins are an important component of complete cancer surgery.

Surgical Videos

Get health updates from Dr Swati Shah on WhatsApp

Swasth Parivar: every week, practical advice on recovery, diet and warning signs. No advertising. Stop any time.

Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.

dr swati shah - uro & gynec cancer surgeon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.